HER2 exon 20 insertions in non-small-cell lung cancer are sensitive to the irreversible pan-HER receptor tyrosine kinase inhibitor pyrotinib

Y. Wang, Fred R. Hirsch, Caicun Zhou et al.|Annals of Oncology|2018

Cited by 217